4536 — Santen Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual balance sheet for Santen Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	C2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	—	—	—	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	63,415	84,307	58,677	94,961	93,994
Net Total Accounts Receivable
Net Total Receivables	95,992	99,591	107,225	90,539	72,083
Total Inventory
Total Other Current Assets
Total Current Assets	206,231	229,426	213,326	236,139	224,300
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	39,489	56,287	66,173	71,576	72,954
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	405,285	459,976	421,179	435,699	409,277
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	78,549	95,821	89,504	92,796	86,837
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	95,104	122,487	127,199	129,645	123,035
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	310,181	337,489	293,980	306,054	286,242
Total Liabilities & Shareholders' Equity	405,285	459,976	421,179	435,699	409,277
Total Common Shares Outstanding